source
- Real-World Data Highlight Survival Benefit of Rituximab Maintenance After Frontline BR in MCLRituximab following first-line bendamustine demonstrated significant OS and EFS real-world benefits in mantle cell lymphoma.onclive · 2mo ago↗ source
- Dr Silbermann on Clinical Trial Design Considerations in Multiple MyelomaRebecca Silbermann, MD, MMS, outlines key trial design considerations in multiple myeloma, including supportive care measures and end point selection.onclive · 2mo ago↗ source
- Supreme Court temporarily extends women’s access to a widely used abortion pillThe Supreme Court is temporarily extending access to a widely used abortion pill while it considers whether to allow restrictions on the drug to take effect.